<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Neurological Complications Reported During and After SARS-CoV-1 Infection.</p>
 </caption>
 <alt-text id="al0055">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>
     <bold>No.</bold>
    </th>
    <th>
     <bold>Neurological</bold>
     <break/>
     <bold>Symptom</bold>
    </th>
    <th>
     <bold>Ref. No.</bold>
    </th>
    <th>
     <bold>No. of patients</bold>
    </th>
    <th>
     <bold>Mean Age of the patients(Range)</bold>
    </th>
    <th>
     <bold>Notes</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="6">
     <bold>Symptoms related to CNS</bold>
    </td>
   </tr>
   <tr>
    <td>
     <bold>1</bold>
    </td>
    <td>Ischemic stroke</td>
    <td>[
     <xref rid="bb0105" ref-type="bibr">21</xref>]
    </td>
    <td>5 Patients
     <break/>3F
     <break/>2M
    </td>
    <td>57.6(39–68)</td>
    <td>Large artery ischemic stroke especially in critically ill patients.</td>
   </tr>
   <tr>
    <td>
     <bold>2</bold>
    </td>
    <td>Headache</td>
    <td>[
     <xref rid="bb0110" ref-type="bibr">22</xref>]
    </td>
    <td>F</td>
    <td>62</td>
    <td/>
   </tr>
   <tr>
    <td>
     <bold>3</bold>
    </td>
    <td>Seizure</td>
    <td>[
     <xref rid="bb0115" ref-type="bibr">23</xref>]
    </td>
    <td>F</td>
    <td>32</td>
    <td>CSF positive for SARS-CoV-1</td>
   </tr>
   <tr>
    <td>
     <bold>4</bold>
    </td>
    <td>Encephalitis</td>
    <td>[
     <xref rid="bb0120" ref-type="bibr">24</xref>]
    </td>
    <td>M</td>
    <td>39</td>
    <td>Autopsy tissue from the patient revealed neuronal necrosis, glial cell hyperplasia, and infiltration of monocytes and T cells.</td>
   </tr>
   <tr>
    <td colspan="6">  </td>
   </tr>
   <tr>
    <td colspan="6">
     <bold>Symptoms related to peripheral nervous system (PNS)</bold>
    </td>
   </tr>
   <tr>
    <td>
     <bold>5</bold>
    </td>
    <td>Guillain-Barré syndrome (GBS)</td>
    <td>[
     <xref rid="bb0125" ref-type="bibr">25</xref>]
    </td>
    <td>3F</td>
    <td>47(42–51)</td>
    <td>Both acute inflammatory demyelinating polyneuropathy (AIDP)
     <break/>and acute motor axonal neuropathy (AMAN)
    </td>
   </tr>
   <tr>
    <td>
     <bold>6</bold>
    </td>
    <td>Critical illness polyneuropathy</td>
    <td>[
     <xref rid="bb0130" ref-type="bibr">26</xref>]
    </td>
    <td>F</td>
    <td>51</td>
    <td/>
   </tr>
   <tr>
    <td/>
    <td>Smell impairment</td>
    <td>[
     <xref rid="bb0135" ref-type="bibr">27</xref>]
    </td>
    <td>F</td>
    <td>27</td>
    <td/>
   </tr>
   <tr>
    <td colspan="6">
     <bold>Symptoms related Skeletal Muscle injury</bold>
    </td>
   </tr>
   <tr>
    <td>
     <bold>7</bold>
    </td>
    <td>Myopathy</td>
    <td>[
     <xref rid="bb0140" ref-type="bibr">28</xref>] [
     <xref rid="bb0125" ref-type="bibr">25</xref>],
    </td>
    <td>5 M</td>
    <td>54.8(31–81)</td>
    <td>Leung TW et al. [
     <xref rid="bb0140" ref-type="bibr">28</xref>] study was a post-mortem study, steroid-induced myopathy suggested for these patients.(4 cases)
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <bold>Abbreviation:</bold> M: Male, F: Female
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
